After completing this educational activity, participants will be able to:
Describe the proposed mechanisms of action, clinical indications, and current evidence base for commonly utilized peptides in the context of aging and skin health, including known limitations and safety considerations.
Assess the role of regenerative and alternative skin therapies, including platelet-rich plasma (PRP), by reviewing available clinical data, appropriate patient selection, procedural considerations, and reported outcomes.
Interpret hormone testing in aging adults, including indications for testing, clinically relevant laboratory markers, and potential sources of variability in results for both men and women.
Evaluate hormone optimization strategies for aging patients, with attention to evidence-supported benefi ts, potential risks, contraindications, and recommended monitoring practices.
Apply an evidence-informed, patient-centered framework to integrate peptides, skin-directed therapies, and hormone management into clinical decision-making while adhering to ethical, regulatory, and safety standards.
Define and recognize the clinical spectrum of perimenopause
Evaluate lifestyle medicine interventions with the strongest evidence for symptom mitigation and long-term health outcomes in perimenopause, including strength training, nutrition strategies, sleep optimization, and stress physiology.
Integrate lifestyle-based and medical management strategies for perimenopause in both personal health and clinical practice, with an emphasis on practical, sustainable approaches for high-demand professional lives. 
Review the menopausal transition timeline
Discuss physiologic changes that occur during this time; with an emphasis on cardiometabolic changes
Discuss evidence behind pharmacologic treatments including the risks and benefits